CD34+ cells derived from AML patients further validated CLIC4 overexpression in AML (47 AML CD34+ vs. 31 normal CD34+, GSE30029, P = 0.04) (Figure 1C). This evidence concerns the gene CD34 and acute myeloid leukemia.